WILMINGTON, Mass.--(BUSINESS WIRE)--CardioTech International, Inc. (AMEX: CTE), a leading developer and manufacturer of advanced biomaterials for a broad range of medical devices, today reported financial results for the fiscal fourth quarter and year ended March 31, 2008. The Company’s financial condition and results of operations, which are based on the Company’s continuing operations, exclude the financial condition and results of Gish Biomedical, Inc. and Catheter and Disposables Technology, Inc. (“CDT”), both former wholly-owned subsidiaries the Company, which were sold during the fiscal year ended March 31, 2008.
